Appendix 3 – PME+ Methodology for Comparing Synthetic Private Equity Funds to Public Market IndexCambridge Associates Healthcare VC Fund Methodology Document
Duplicate Document
This document appears to be a copy. The original version is:
Financial performance disclaimer for NLV and Sprout FundsCase Filekaggle-ho-024108House OversightFinancial performance disclaimer for NLV and Sprout Funds
Unknown1p5 persons
Case File
kaggle-ho-024108House OversightFinancial performance disclaimer for NLV and Sprout Funds
Financial performance disclaimer for NLV and Sprout Funds The passage contains only standard investment performance disclosures and methodological notes with no specific actors, transactions, or allegations. It offers no actionable leads for investigation. Key insights: Performance data is unaudited and as of March 31, 2014.; Returns are presented on gross and net bases, with fees and carried interest noted.; Disclaimers emphasize that past performance is not indicative of future results.
Date
Unknown
Source
House Oversight
Reference
kaggle-ho-024108
Pages
1
Persons
5
Integrity
No Hash Available
Loading document viewer...
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,500+ persons in the Epstein files. 100% free, ad-free, and independent.
Support This ProjectSupported by 1,550+ people worldwide
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.